<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(15)</volume><submitter>Lin H</submitter><pubmed_abstract>Heat stress, clinically known as hyperthermia, is a promising adjunctive modality in cancer treatment. However, the efficacy of hyperthermia as a monotherapy is limited and the underlying mechanism remains poorly understood. Targeting histone modifications is an emerging strategy for cancer therapy, but little is known regarding the role of heat stress in altering these modifications. Here, we report that heat shock inhibits H3K9 acetylation (H3K9ac) via histone deacetylase 6 (HDAC6) regulation. Heat shock inhibits the interaction between HDAC6 and heat shock protein 90 (HSP90), enhances nuclear localization of HDAC6, and promotes HDAC6 phosphorylation, which is regulated by protein phosphatase 2A (PP2A). Combining hyperthermia with HDAC inhibitors vorinostat or panobinostat leads to bette</pubmed_abstract><journal>International journal of biological sciences</journal><pagination>4849-4864</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10539700</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of Heat Shock-Induced H3K9ac Reduction Sensitizes Cancer Cells to Hyperthermia.</pubmed_title><pmcid>PMC10539700</pmcid><pubmed_authors>Song L</pubmed_authors><pubmed_authors>Cheng R</pubmed_authors><pubmed_authors>Lei Y</pubmed_authors><pubmed_authors>Guo F</pubmed_authors><pubmed_authors>Lin H</pubmed_authors><pubmed_authors>Geng Z</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of Heat Shock-Induced H3K9ac Reduction Sensitizes Cancer Cells to Hyperthermia.</name><description>Heat stress, clinically known as hyperthermia, is a promising adjunctive modality in cancer treatment. However, the efficacy of hyperthermia as a monotherapy is limited and the underlying mechanism remains poorly understood. Targeting histone modifications is an emerging strategy for cancer therapy, but little is known regarding the role of heat stress in altering these modifications. Here, we report that heat shock inhibits H3K9 acetylation (H3K9ac) via histone deacetylase 6 (HDAC6) regulation. Heat shock inhibits the interaction between HDAC6 and heat shock protein 90 (HSP90), enhances nuclear localization of HDAC6, and promotes HDAC6 phosphorylation, which is regulated by protein phosphatase 2A (PP2A). Combining hyperthermia with HDAC inhibitors vorinostat or panobinostat leads to bette</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-06-25T03:04:23.104Z</modification><creation>2025-04-06T16:50:45.277Z</creation></dates><accession>S-EPMC10539700</accession><cross_references><pubmed>37781518</pubmed><doi>10.7150/ijbs.86384</doi></cross_references></HashMap>